Source: NASDAQ US Markets / 10 Dec 2023 07:46:15 America/New_York
With shares of AstraZeneca (NASDAQ: AZN) returning 55% over the last three years, easily topping the market's return of 29%, it's no surprise why investors might be curious about whether there's more upside in store.
https://www.nasdaq.com/articles/is-now-the-right-time-to-buy-astrazeneca-stock